Sjogren's Syndrome: Clinical Benefits of Low-dose Naltrexone Therapy

Cureus
11 March 2019
https://pubmed.ncbi.nlm.nih.gov/31123647/

Sjogren's Syndrome and Clinical Benefits of Low-Dose Naltrexone Therapy: Additional Case Reports

Cureus
July 2020
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398709/

Scott Zashin MD - Treatment of Sjogren's Syndrome with LDN (2017 Conference) (LDN, low dose naltrexone)

In this presentation Dr Scott Zashin discusses the diagnosis of Sjogren’s Syndrome and its symptoms, including a dryness of the eyes or the mouth.

Shonna - 7th August 2019 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Elsegood. Today I'm joined by Shonna from the United States who uses LDN for chronic fatigue syndrome, Sjogren's, and she has had other conditions that we will learn about.

Thank you for joining us today. Shona. 

Amy on the LDN Radio Show - 13th December 2017 (Low dose naltrexone) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Amy from the United States shares her Sjögren's Syndrome and LDN Story on the LDN Radio Show with Linda Elsegood.

Dickson Chemist developed a new formulation of LDN which will hopefully improve the outcomes for patients. This new formulation is a more concentrated liquid in the form of drops which are administered under the tongue and absorbed directly from the mucosal lining of the mouth. This sublingual route produces a more rapid absorption bypassing the liver and digestive tract. There are several potential advantages to this, the drug may be more effective and will not be affected by the presence of food stuffs or the hostile environment of the gut.